	C 2012 Mar 31	C 2013 Mar 31	C 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	R 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Total Revenue	13,815	14,711	15,885	17,203	14,873	10,346	10,270	10,337	10,357	10,200	12,622	16,789	15,421	14,887	14,584
Cost of Operating Revenue	8,278	8,846	9,836	10,478	8,650	4,654	4,499	4,874	4,878	5,382	6,566	8,345	7,508	7,516	7,294
Gross Profit	5,537	5,865	6,049	6,725	6,223	5,692	5,771	5,463	5,478	4,818	6,057	8,444	7,913	7,371	7,290
Gross Margin	40.1	39.9	38.1	39.1	41.8	55.0	56.2	52.9	52.9	47.2	48.0	50.3	51.3	49.5	50.0
Total Operating Expenses	12,022	12,896	14,438	15,312	13,221	8,742	8,576	9,101	9,052	9,429	11,103	13,801	13,495	14,057	13,980
Operating Profit	1,793	1,815	1,447	1,891	1,652	1,604	1,694	1,236	1,305	771	1,519	2,988	1,926	830	604
Operating Margin	13.0	12.3	9.1	11.0	11.1	15.5	16.5	12.0	12.6	7.6	12.0	17.8	12.5	5.6	4.1
Financing Income/(Expense) - Net	-231	-309	-542	-535	-496	-188	-185	-47	-148	-235	-111	-263	-338	-394	-344
Profit before Taxes	1,383	913	-519	1,159	1,180	1,467	1,620	1,437	1,248	634	1,667	2,740	830	521	-1,459
Income Taxes	344	303	289	351	248	346	60	274	220	198	266	288	381	167	256
Profit after Tax	838	400	-1,032	596	771	993	2,433	1,156	7,006	256	1,258	2,317	268	235	-1,896
PAT Margin	6.1	2.7	-6.5	3.5	5.2	9.6	23.7	11.2	67.6	2.5	10.0	13.8	1.7	1.6	-13.0
EPS - Basic - ex Extraordinary Items	32.88	15.72	-40.51	23.41	27.33	34.53	50.66	36.58	31.66	10.06	49.17	91.66	11.07	7.93	-74.42
EPS - Diluted - ex Extraordinary Items	32.88	15.72	-40.51	23.41	27.33	34.53	50.66	36.58	31.66	10.06	49.17	91.66	11.07	7.93	-74.42
EBIT	1,793	1,815	1,447	1,891	1,652	1,604	1,694	1,236	1,305	771	1,519	2,988	1,926	830	604
EBITDA	2,301	2,349	1,919	2,354	2,178	2,157	2,212	1,804	1,971	1,530	2,324	3,878	2,905	1,951	1,804
EBITDA Margin	16.7	16.0	12.1	13.7	14.6	20.8	21.5	17.5	19.0	15.0	18.4	23.1	18.8	13.1	12.4

Balance Sheet

Abridged

Understanding Balance Sheet

Tata Chemicals Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	C 2013 Mar 31	R 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	IR	AR	AR	AR	AR	AR	AR
Total Current Assets	6,427	7,505	7,348	8,101	7,579	7,374	9,040	8,098	7,799	6,646	8,745	8,164	6,367	6,720	7,206
Long-Term Investments	606	402	222	2,077	1,841	2,280	2,424	2,520	1,935	3,355	5,177	5,094	7,693	7,068	7,752
Property Plant & Equipment - Net	4,899	4,621	4,684	4,460	4,727	4,190	4,361	5,029	6,170	6,679	7,790	8,920	9,427	10,673	11,747
Total Non-Current Assets	12,607	12,734	12,824	16,348	16,777	16,236	16,839	18,807	19,890	21,691	25,098	26,920	30,389	31,060	31,825
Total Assets	19,034	20,239	20,172	24,449	24,355	23,610	25,879	26,905	27,689	28,337	33,843	35,084	36,756	37,780	39,031
Total Current Liabilities	5,211	6,218	5,130	6,541	5,025	5,606	3,703	3,949	7,025	4,463	7,096	4,904	6,055	6,139	6,743
Long Term Debt	5,489	5,461	6,883	5,759	6,780	4,361	5,394	4,783	3,661	5,388	3,861	5,677	3,289	4,816	5,377
Total Non-Current Liabilities	7,039	7,071	8,821	8,846	9,877	7,473	8,356	7,700	7,002	8,731	7,590	9,538	7,587	9,140	10,113
Total Liabilities	12,250	13,289	13,951	15,387	14,902	13,078	12,060	11,649	14,027	13,195	14,686	14,442	13,642	15,279	16,856
Total Shareholders' Equity	6,336	6,414	5,566	6,586	6,854	7,908	11,102	12,341	12,898	14,290	18,253	19,721	22,241	21,594	21,206
Minority Interest	448	536	655	2,476	2,598	2,624	2,717	2,915	764	853	905	921	873	907	969
Total Equity	6,784	6,950	6,221	9,062	9,453	10,532	13,819	15,256	13,661	15,143	19,157	20,642	23,114	22,501	22,175
Total Liabilities & Equity	19,034	20,239	20,172	24,449	24,355	23,610	25,879	26,905	27,689	28,337	33,843	35,084	36,756	37,780	39,031

Cash Flow

Abridged

Understanding Cash Flow Statement

Tata Chemicals Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	R 2013 Mar 31	R 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	1,691	1,563	1,520	2,061	1,892	1,966	3,487	1,670	8,166	1,470	2,131	3,486	2,487	1,774	1,858
Working Capital - Increase/(Decrease)	-841	-1,711	380	-1,118	-65	1,213	-569	-214	-314	323	-649	-679	332	-174	-819
Net CF from Operating Activities	850	-147	1,900	944	1,827	3,179	2,918	1,456	7,852	1,793	1,482	2,807	2,819	1,600	1,039
Capital Expenditures - Net	761	584	594	565	687	643	731	1,080	1,169	1,233	1,265	1,544	1,823	1,952	1,140
Net CF from Investing Activities	-881	-334	-615	-768	-604	-1,076	20	-2,691	-2,521	-1,232	-929	-1,366	-859	-1,937	-1,066
Dividends Paid - Cash - Total	319	303	296	303	382	306	336	673	382	280	255	319	447	382	280
Debt - LT & ST - Issuance/(Retirement) - Total	781	1,029	-785	-184	-610	-1,412	-1,241	-576	735	-740	-149	-1,314	-1,271	945	218
Net Cash Flow from Financing Activities	285	593	-1,285	-644	-1,181	-1,896	-1,765	-1,418	180	-1,110	-500	-1,732	-2,048	446	-183
Free Cash Flow to Equity	871	297	521	195	531	1,125	947	-200	7,418	-180	67	-51	-275	593	117
Free Operating CF net dividend	-264	-1,076	901	36	756	2,228	1,831	-299	6,270	271	-50	910	538	-787	-446
Free Operating CF	55	-773	1,197	338	1,138	2,534	2,168	373	6,653	551	205	1,229	985	-405	-166

Business Segment Analysis

FY End:

Mar 26

Tata Chemicals Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Basic Chemistry products (92.9%)₹ 1,306.00 CrSpeciality Products (6.4%)₹ 90.00 CrUnallocated (0.7%)₹ 10.00 Cr

Revenue / Sales

Basic Chemistry products (78.9%)₹ 11,508.00 CrSpeciality Products (21.1%)₹ 3,076.00 Cr

Assets

Basic Chemistry products (61.5%)₹ 24,004.00 CrUnallocated (29.9%)₹ 11,653.00 CrSpeciality Products (8.6%)₹ 3,374.00 Cr

Regional Segment Analysis

FY End:

Mar 26

Tata Chemicals Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (48.8%)₹ 7,111.00 CrUSA (22.1%)₹ 3,221.00 CrUnited Kingdom (9.2%)₹ 1,335.00 CrAsia(Other than India) (8.9%)₹ 1,303.00 CrAmerica (4.3%)₹ 621.00 CrNorthern America (3.0%)₹ 440.00 CrAfrica (2.0%)₹ 295.00 CrOthers. (1.1%)₹ 154.00 CrEurope (0.7%)₹ 104.00 Cr

Historical Segment Analysis

Track how Tata Chemicals Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Basic Chemistry products	-	-	-	-	-	-	-	603	729	1,252	948	1,620	1,475	1,979	2,119	1,306
Speciality Products	-	-	-	-	-	-	-	82	409	209	196	183	260	263	118	90
Unallocated	7	8	16	16	24	20	11	27	10	75	50	24	5	15	33	10
Fertilizers	60	139	180	106	73	3	-	-	-	-	-	-	-	-	-	-
Inorganic Chemicals	368	295	517	406	446	524	592	-	-	-	-	-	-	-	-	-
Other Agri inputs	119	158	229	41	59	77	44	-	-	-	-	-	-	-	-	-
Others	25	19	28	12	39	6	6	-	-	-	-	-	-	-	-	-
Consumer products	-	-	-	-	-	-	-	5	-	-	-	-	-	-	-	-

Frequently Asked Questions

What is the revenue of Tata Chemicals Ltd.?

The latest trailing twelve month revenue of Tata Chemicals Ltd. is ₹ 14,584.00 Cr, reflecting a 1-year growth of -2.04% and a 3-year CAGR of -4.58%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Tata Chemicals Ltd.?

The latest trailing twelve month net profit (PAT) of Tata Chemicals Ltd. is ₹ -1,896.00 Cr, with a 3-year earnings CAGR of -41.15%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Tata Chemicals Ltd.?

The trailing twelve month EBITDA of Tata Chemicals Ltd. is approximately ₹ 604.00 Cr (based on an operating margin of 4.14%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Tata Chemicals Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Tata Chemicals Ltd. is -74.42. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Tata Chemicals Ltd.?

The debt-to-equity ratio of Tata Chemicals Ltd. stands at 0.38. The interest coverage ratio is 1.02x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Tata Chemicals Ltd.?

The estimated book value per share of Tata Chemicals Ltd. is 837.66 (derived from a P/B ratio of 0.83 and market price of ₹ 693.10), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Tata Chemicals Ltd.?

The trailing twelve month operating cash flow of Tata Chemicals Ltd. is ₹ 1,039.00 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Tata Chemicals Ltd. report consolidated or standalone financials?

Tata Chemicals Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.